Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Egetis Therapeutics AB (publ)

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 57,600 Less Arrow 22,600 More Arrow 38,243
Financial expenses 6,900 Less Arrow 700 Less Arrow 188
Earnings before taxes -326,800 More Arrow -193,800 More Arrow -104,542
EBITDA -321,200 More Arrow -195,400 More Arrow -103,226
Total assets 760,200 Less Arrow 561,100 More Arrow 569,269
Current assets 345,900 Less Arrow 147,400 More Arrow 152,902
Current liabilities 103,900 Less Arrow 49,400 Less Arrow 39,170
Equity capital 545,600 Less Arrow 506,200 More Arrow 527,039
- share capital 15,400 Less Arrow 11,300 Less Arrow 8,688
Employees (average) 27 Less Arrow 15 Less Arrow 11

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 71.8% More Arrow 90.2% More Arrow 92.6%
Turnover per employee 2,133 Less Arrow 1,507 More Arrow 3,477
Profit as a percentage of turnover -567.4% Less Arrow -857.5% More Arrow -273.4%
Return on assets (ROA) -42.1% More Arrow -34.4% More Arrow -18.3%
Current ratio 332.9% Less Arrow 298.4% More Arrow 390.4%
Return on equity (ROE) -59.9% More Arrow -38.3% More Arrow -19.8%
Change turnover 35,000 Less Arrow -15,643 More Arrow -2,419
Change turnover % 155% Less Arrow -41% More Arrow -6%
Chg. No. of employees 12 Less Arrow 4 Less Arrow 2
Chg. No. of employees % 80% Less Arrow 36% Less Arrow 22%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.